Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

作者：Julie K. Jadlowsky, Elizabeth Olson Hexner, Amy Marshall, Stephan A. Grupp, Noelle V. Frey, James L. Riley, Elizabeth A. Veloso, Holly McConville, Walter Rogal, Cory Czuczman, Wei‐Ting Hwang, Yimei Li, Rachel M. Leskowitz, Olivia M. Farrelly, Jayashree Karar, Shannon R. Christensen, Julie S. Barber-Rotenberg, Avery L. Gaymon, Naomi Aronson, Wendy Bernstein, Jan Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Sonja A. Zolnoski, Alexander G. McFarland, Shantan G. Reddy, Angelina Petrichenko, Emma J. Cook, Carole Lee, Vanessa E. Gonzalez, Kathleen A. Alexander, Irina M. Kulikovskaya, Ángel Ramírez-Fernández, Janna C. Minehart, Marco Ruella, Saar I. Gill, Stephen J. Schuster, Adam D. Cohen, Alfred L. Garfall, Payal Deepak Shah, David L. Porter, Shannon L. Maude, Bruce L. Levine, Don L. Siegel, Anne Chew, Stephen James McKenna, Lester Lledo, Megan M. Davis, Gabriela Plesa, Friederike Herbst, Edward Allen Stadtmauer, Pablo Tebas, Amanda M. DiNofia, A. Haas, Naomi Balzer Haas, Regina M. Myers, Donald M. O’Rourke, Jakub Svoboda, Janos Laszlo Tanyi, Richard Aplenc, Jeffrey M. Jacobson, Andrew H. Ko, Roger B. Cohen, Carl H. June, Frederic D. Bushman, Joseph A. Fraietta · 发表于：Nature Medicine · 年份：2025 · DOI：10.1038/s41591-024-03478-6 · 被引用次数：78 · 研究领域：CAR-T cell therapy research、Virus-based gene therapy research、CRISPR and Genetic Engineering